Alzheimer’s Disease Assessment Scale–Cognitive subscale variants in mild cognitive impairment and mild Alzheimer’s disease: change over time and the effect of enrichment strategies

Overview of attention for article published in Alzheimer's Research & Therapy, February 2016

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

So far, Altmetric has seen 6 news stories from 3 outlets.

March 16th, 2023 Senolytic drugs are those that selectively force senescent cells into programmed cell death.

Follow Summary Aricept, blarcamesine, simufilam, and panax ginseng by acting as acetylcholinesterase inhibitors and as indirect…

Follow Summary Cassava Sciences' phase 2 data was from a nonrandomized trial, therefore unconvincing.

Follow Summary The Phase 2b/3 trial of Anavex's Blarcamesine demonstrates major, statistically significant effects in slowing…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 2 additional news stories.